Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05307952
Other study ID # 2022-13495
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 30, 2022
Est. completion date December 2024

Study information

Verified date June 2023
Source Radboud University Medical Center
Contact Wendy Huinck, PhD
Phone +31243613506
Email Wendy.Huinck@radboudumc.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this study is to assess the effectiveness of an integrated program of fitting and training interventions aimed at reducing unexpected variability and addressing the specific error patterns of each recipient. The participants will undergo 1 visit lasting approximately 2 hours at the Radboud university medical center's ENT department, where they will undergo a series of diagnostic tests. Some of the participants will also be asked to self-administer additional tests using a Windows tablet. Based on the outcomes of speech recognition tests in quiet at the first visit, the participants will be called for follow-up interventions concerning both the fitting of their CI and personalized auditory training based on their personal error patterns. These interventions will take place over the course of approximately 5 months and will be made up of three follow-up visits and a period of self-administered training through a mobile application on a tablet. One final follow-up visit will check whether any changes from the interventions are retained after four weeks.


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date December 2024
Est. primary completion date October 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult (over 18 years old at the time of inclusion ) - Post-lingually deafened (the subject had a good mastery of spoken language before onset of deafness) - Native Dutch speaker - Implanted, either unilaterally or bilaterally, with a Cochlear Implant manufactured by Cochlear Ltd (i.e., a Nucleus ® implant). - Implanted with one of the following implants: CI422, CI512, CI522, CI532, CI24M, CI24R, CI24RE. - Implanted for at least 12 months. Exclusion Criteria: - Known abnormally formed cochlea - Known pre-implantation ossification of the cochlea - Severe cognitive disorders affecting their ability to understand spoken language - Intense facial nerve stimulation - Unaddressed electrode tip foldover - More than 4 electrodes deactivated because of malfunction (open/short circuit) or lack of response - Additional illnesses or handicaps that could impact ability to participate in study, at the clinician's discretion.

Study Design


Intervention

Diagnostic Test:
Tone Audiometry
Evaluation of the participants' audiometrical thresholds
Spectrotemporal Assessment
Evaluation of the participants' promptness in detecting a modulation of a harmonic complex
Phoneme and Speech Perception
Evaluation of the participants' understanding of phonemes and short words, both in quiet and in noise
Digit Triplet Test
Evaluation of the participants' ability to discern speech in noise
Other:
Personalized fitting
Adjustment of the parameters of the participants' cochlear implants aimed at improving their speech perception
Behavioral:
Personalized training
Self-administered training exercises focused on the speech components the participants are experiencing difficulties into

Locations

Country Name City State
Netherlands Radboud university medical center Nijmegen Gelderland

Sponsors (2)

Lead Sponsor Collaborator
Radboud University Medical Center Cochlear

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Percent Speech Recognition Given a list of CNC words, this score measures the percentage of correctly identified words. Weeks 1, 10, 14, 18
Secondary Change in Distance-based Accuracy Score Speech Recognition accuracy score based on phoneme distance, such that mistaking a phoneme for a similar one such as mistaking /k/ for /g/ gives a lower penalty than mistaking a phoneme for a very different one. Weeks 1, 10, 14, 18
Secondary Change in Error Dispersion Mathematical quantification of how much the errors made by the subjects are spread between stimuli and responses Weeks 1, 10, 14, 18
See also
  Status Clinical Trial Phase
Completed NCT05073796 - Cochlear Implant Electrostimulation and the Influence on the Vestibular Organ N/A
Completed NCT05795530 - Vestibular Function in Cochlear Implants
Completed NCT03260062 - Parent-Child Early Approaches to Raising Language Skills (PEARLS) Intervention N/A